Synapse - Magdalena Corona De Lapuerta

Results (28)

Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma

Journal Article

Corona, M.; Ip, A.; Brown, S.; Luna, A.; Khatib, H.; Flynn, J. R.; Devlin, S. M.; Landego, I.; Cassanello, G.; Rejeski, K.; more...
Bone Marrow Transplantation (2025)

Fulltext@MSK | Save

CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma

Journal Article

Luna, A.; Devlin, S. M.; Rejeski, K.; Flynn, J. R.; Corona, M.; Luttwak, E.; Rivas-Delgado, A.; Landego, I.; Cassanello, G.; Gomez-Llobell, M.; more...
Blood Cancer Journal (2025)

Fulltext@MSK | Save

Dynamics of immune reconstitution and impact on outcomes across CAR-T cell products in large B-cell lymphoma

Journal Article

Luan, D.; DeWolf, S.; Fei, T.; Raj, S.; Shah, G. L.; Lareau, C. A.; Alhomoud, M.; Salles, G.; Rivas-Delgado, A.; Rejeski, K.; more...
Blood Cancer Discovery (2025)

Fulltext@MSK | Save

Shift from widespread to tailored antifungal prophylaxis in lymphoma patients treated with CD19 CAR T cell therapy: Results from a large retrospective cohort

Journal Article

Melica, G.; Luna de Abia, A.; Shah, G. L.; Devlin, S.; Corona, M.; Fein, J.; Dahi, P. B.; Giralt, S. A.; Lin, R. J.; Palomba, M. L.; more...
Transplantation and Cellular Therapy (2025)

Fulltext@MSK | Save

Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes

Journal Article

Valtis, Y. K.; Devlin, S.; Shouval, R.; Rejeski, K.; Corona, M.; De Abia, A. L.; Rivas-Delgado, A.; Luttwak, E.; Cassanello, G.; Landego, I.; more...
Blood Advances (2025)

Fulltext@MSK | Save

CAR T-cell therapy for DLBCL with CNS involvement: Overall safe and effective with limited efficacy in patients with leptomeningeal disease

Meeting Abstract

Luttwak, E.; Cassanello, G.; Brown, S.; Devlin, S. M.; Imber, B. S.; Ip, A.; Leslie, L. A.; Accav, N. G.; Beyar-Katz, O.; Corona, M.; more...
Blood (2024)

Fulltext@MSK | Save

Comparative real-world outcomes of commercial CD19-directed CAR T-cell therapies in large B-cell lymphoma

Meeting Abstract

Deschênes-Simard, X.; Bromberg, M.; Devlin, S. M.; Katz, O. B.; Ip, A.; Marcus, R.; Avigdor, A.; Ballweg, A.; Rabinovich, E.; Alhomoud, M.; more...
Blood (2024)

Fulltext@MSK | Save

When can we define cure after CAR-T therapy in LBCL? insights from serial landmark analyses

Meeting Abstract

Gomez-Llobell, M.; Shouval, R.; Brown, S.; Accav, N. G.; Devlin, S. M.; Corona, M.; Rejeski, K.; Rivas-Delgado, A.; Luna, A.; Luttwak, E.; more...
Blood (2024)

Fulltext@MSK | Save

Patterns of immune reconstitution and their clinical significance in aggressive lymphoma treated with CAR-T therapy

Meeting Abstract

Luan, D. Y.; Dewolf, S.; Fei, T.; Raj, S. S.; Shah, G. L.; Lareau, C.; Alhomoud, M.; Salles, G.; Rivas-Delgado, A.; Rejeski, K.; more...
Blood (2024)

Fulltext@MSK | Save

CAR-tography: Longitudinal mapping of CAR-T toxicities across B-cell malignancies reveals biologically distinct and prognostically relevant toxicity phenotypes

Meeting Abstract

Rejeski, K.; Fei, T.; Luna, A.; Alhomoud, M.; Valtis, Y. K.; Nishimura, N.; Gomez-Llobell, M.; Accav, N. G.; Beyar-Katz, O.; Raj, S. S.; more...
Blood (2024)

Fulltext@MSK | Save